首页|重症肺炎患儿血清sIL-2R、PGRN、Copeptin表达及与其预后的相关性分析

重症肺炎患儿血清sIL-2R、PGRN、Copeptin表达及与其预后的相关性分析

扫码查看
目的:探讨血清可溶性白细胞介素-2 受体(sIL-2R)、血清颗粒蛋白前体(PGRN)、肽素(Copeptin)在重症肺炎患儿中的表达水平,并分析其与重症肺炎预后的相关性.方法:选取某院2021 年1 月—2022 年 12 月收治的肺炎患儿 183 例为研究对象,根据病情严重程度分为重症肺炎组(n =80)和普通肺炎组(n =103),另选取同期 100 例健康体检儿童为健康组.比较 3组受试者入组时血清sIL-2R、PGRN、Copeptin水平,绘制ROC曲线分析各指标对重症肺炎的诊断价值,比较不同预后患儿入组时血清各指标水平及小儿危重病例评分(PCIS)、急性生理慢性健康(APACHEII)评分水平,并分析入组时血清指标预测预后的危险度.结果:重症肺炎组患儿入院时血清 sIL-2R、PGRN、Copeptin 水平分别为(648.47±100.27)U/mL、(36.17±10.47)μg/L、(62.77±14.21)pmol/L),高于普通肺炎组患儿入院时的(461.51±79.64)U/mL、(30.66±7.21)μg/L、(47.66±11.47)pmol/L和健康组的(214.79±39.47)U/mL、(26.31±4.14)μg/L、(11.27±6.94)pmol/L,差异均有统计学意义(P<0.05).入组时血清sIL-2R、PGRN、Copeptin水平联合检测诊断重症肺炎的ROC曲线下面积(AUC)为 0.789.预后不良组患儿血清sIL-2R、PGRN、Copeptin水平及APACHEII评分分别为(715.98±79.51)U/mL、(43.79±8.97)μg/L、(68.49±6.79)pmol/L、(22.81±3.79)分,高于预后良好组患儿的(627.44±45.69)U/mL、(33.82±8.46)μg/L、(60.99±7.21)pmol/L、(20.16±3.68)分,PCIS 评分为(72.14±6.44)分,低于预后良好组患儿的(81.51±7.41)分,差异均有统计学意义(P<0.05).血清sIL-2R、PGRN、Copeptin水平与PCIS评分均呈负相关,与APACHEII评分均呈正相关(P<0.05).入组时血清sIL-2R、PGRN、Copeptin高水平患儿发生预后不良的危险度是低水平的2.981、4.637、3.458 倍,差异有统计学意义(P<0.05).结论:重症肺炎患儿血清sIL-2R、PGRN、Copeptin表达水平升高,与重症肺炎预后密切相关,可作为预测预后的辅助指标.
Expression of serum sIL-2R,PGRN and Copeptin in children with severe pneumonia and their correlation with prognosis
Objective:To investigate the expression of serum soluble interleukin-2 receptor(sIL-2R),serum granuloprotein precur-sor(PGRN),and peptide(Copeptin)in children with severe pneumonia,and to analyze their correlation with prognosis.Methods:A total of 183 children with pneumonia admitted to our hospital from January 2021 to December 2022 were selected as the study objects.According to the severity of the disease,the patients were divided into a severe pneumonia group(n =80)and a common pneumonia group(n =103),and another 100 healthy children were selected as the healthy group.Serum levels of sIL-2R,PGRN and Copeptin were compared between the three groups at admission,and the diagnostic value of each index was analyzed by ROC.The levels of ser-um indicators,critical case score(PCIS)and acute physiological chronic health score(APACHEII)of children with different progno-sis were compared at admission,and the risk of poor prognosis in children with different levels of serum indicators at admission was an-alyzed.Results:The levels of serum sIL-2R,PGRN,and Copeptin in the severe pneumonia group(648.47±100.27 U/mL,36.17±10.47 μg/L,62.77±14.21 pmol/L)were higher than those in the common pneumonia group(461.51±79.64U/mL,30.66±7.21μg/L,47.66±11.47pmol/L)and those in the healthy group(214.79±39.47 U/mL,26.31±4.14 μg/L,11.27±6.94 pmol/L)(P<0.05).The AUC of serum sIL-2R,PGRN,and Copeptin levels at admission in combined detection for the diagnosis of severe pneumonia was 0.789.The serum sIL-2R,PGRN,Copeptin,and APACHEII scores of children with poor prognosis were(715.98±79.51 U/mL,43.79±8.97 μg/L,68.49±6.79 pmol/L,22.81±3.79),which were higher than those of children with good prog-nosis(627.44±45.69 U/mL,33.82±8.46 μg/L,60.99±7.21 pmol/L,20.16±3.68).The PCIS score of children with poor prognosis(72.14±6.44 scores)was lower than that of children with good prognosis(81.51±7.41),with significant differences(P<0.05).Serum sIL-2R,PGRN and Copeptin were negatively correlated with PCIS score and positively correlated with APACHEII score(P<0.05).The risk of poor prognosis in children with high levels of serum sIL-2R,PGRN and Copeptin at admission was 2.981,4.637,and 3.458 times of that with low levels(P<0.05).Conclusion:Serum sIL-2R,PGRN and Copeptin are significantly expressed in children with severe pneumonia,which is closely related to the prognosis of severe pneumonia,and can be used as auxiliary indicators to predict the prognosis of children with severe pneumonia.

Severe pneumoniasIL-2RPGRNCopeptinPrognosis

梁惠如、彭二扣、宋瑞

展开 >

河南省商丘市第一人民医院新生儿重症监护室,476000

河南省商丘市第一人民医院儿童重症监护室,476000

重症肺炎 sIL-2R PGRN Copeptin 预后

2024

淮海医药
蚌埠市医学科学情报站 《淮海医药》编辑部

淮海医药

影响因子:0.58
ISSN:1008-7044
年,卷(期):2024.42(2)
  • 20